A Real-World Evaluation of Risk Factors for Disease Progression in Patients With Polycythemia Vera (PV): An Analysis From the Prospective Observational Study of Patients With Polycythemia Vera in US Clinical Practices (REVEAL)

被引:0
|
作者
Grunwald, Michael R. [1 ]
Zwicker, Jeffrey I. [2 ,3 ]
Gerds, Aaron T. [4 ]
Burke, John M. [5 ]
Xue, Zhenyi [6 ]
Crowgey, Erin L. [6 ]
Carl, Justine [6 ]
Feldman, Patricia [6 ]
Braunstein, Evan M. [6 ]
Oh, Stephen T. [7 ]
机构
[1] Atrium Hlth, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Weill Cornell Med Coll, Dept Med, New York, NY USA
[4] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[5] Rocky Mt Canc Ctr, Aurora, CO USA
[6] Incyte Corp, Wilmington, DE USA
[7] Washington Univ, Sch Med, St Louis, MO USA
来源
关键词
MPN; polycythemia vera; progression; risk factors;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MPN-120
引用
收藏
页码:S415 / S416
页数:2
相关论文
共 50 条
  • [31] Real-World Dosing Patterns of Ruxolitinib in Patients with Polycythemia Vera Who are Resistant to or Intolerant of Hydroxyurea
    Altomare, Ivy
    Nguyen, Anna
    Parasuraman, Shreekant
    Paranagama, Dilan
    Kish, Jonathan K.
    Lord, Kevin
    Colucci, Philomena
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S326 - S327
  • [32] Real-World Dosing Patterns of Ruxolitinib in Patients with Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea
    Altomare, Ivy
    Nguyen, Anna
    Parasuraman, Shreekant
    Paranagama, Dilan
    Kish, Jonathan K.
    Lord, Kevin
    Colucci, Philomena
    BLOOD, 2019, 134
  • [33] Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea
    Altomare, Ivy
    Parasuraman, Shreekant
    Paranagama, Dilan
    Kish, Jonathan
    Lord, Kevin
    Yu, Jingbo
    Colucci, Philomena
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (11): : E915 - E921
  • [34] EVALUATION OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA IN THE PROVINCE OF AVILA
    Davila Valls, J.
    Rodriguez Dominguez, M. J.
    Recio Rueda, I
    Martinez Badas, M. P.
    Gonzalez Mena, B.
    Cabezudo Moreno, M.
    Barez Garcia, A.
    HAEMATOLOGICA, 2017, 102 : 285 - 286
  • [35] ACUTE-LEUKEMIA (AL), HYDROXYUREA (HU) AND POLYCYTHEMIA-VERA (PV) - AN ANALYSIS OF RISK FROM THE POLYCYTHEMIA-VERA STUDY-GROUP (PVSG)
    FRUCHTMAN, SM
    KAPLAN, ME
    PETERSON, P
    MACK, K
    BERK, PD
    WASSERMAN, LR
    BLOOD, 1994, 84 (10) : A518 - A518
  • [36] Real-World Use and Outcome of Ropeginterferon ALFA-2B in Polycythemia VERA Patients: A Multicenteric Study
    Pugliese, Novella
    Di Perna, Maria
    De Martino, Ugo
    Amico, Valeria
    Annunziata, Mario
    Martorelli, Maria Carmen
    Abagnale, Davide Pio
    Russo, Roberta
    Ferrentino, Maria
    Scarpa, Alessia
    Muriano, Francesco
    Martinelli, Vincenzo
    Pane, Fabrizio
    BLOOD, 2024, 144 : 6651 - 6651
  • [37] Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL Study
    Grunwald, Michael R.
    Burke, John M.
    Kuter, David J.
    Gerds, Aaron T.
    Stein, Brady
    Walshauser, Mark A.
    Parasuraman, Shreekant
    Colucci, Philomena
    Paranagama, Dilan
    Savona, Michael R.
    Mesa, Ruben
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (09): : 579 - +
  • [38] Low-Risk Polycythemia Vera Treated with Phlebotomies: Clinical Characteristics, Hematologic Control and Complications in 358 Patients from the Spanish Registry of Polycythemia Vera
    Triguero, Ana
    Pedraza, Alexandra
    Perez, Manuel
    Mata, Maria Isabel
    Bellosillo, Beatriz
    Fox, Maria Laura
    Gomez, Montserrat
    Garcia-Delgado, Regina
    Kabat, Mercedes Gasior
    Marin, Francisca Ferrer
    Gutierrez, Valentin Garcia
    Angona, Anna
    Gomez-Casares, Maria Teresa
    Cuevas, Beatriz
    Martinez, Clara
    Lopez, Raul Perez
    Sanchez, Jose Maria Raya
    Guerrero, Lucia
    Murillo, Ilda Maria
    Castillo, Carlos
    Sanz, Cristina
    Boluda, Juan Carlos Hernandez
    Alvarez-Larran, Alberto
    BLOOD, 2021, 138
  • [39] Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera
    Triguero, Ana
    Pedraza, Alexandra
    Perez-Encinas, Manuel
    Isabel Mata-Vazquez, Maria
    Velez, Patricia
    Fox, Laura
    Gomez-Calafat, Montse
    Garcia-Delgado, Regina
    Gasior, Mercedes
    Ferrer-Marin, Francisca
    Garcia-Gutierrez, Valentin
    Angona, Anna
    Teresa Gomez-Casares, Maria
    Cuevas, Beatriz
    Martinez, Clara
    Perez, Raul
    Maria Raya, Jose
    Guerrero, Lucia
    Murillo, Ilda
    Bellosillo, Beatriz
    Carlos Hernandez-Boluda, Juan
    Sanz, Cristina
    Alvarez-Larran, Alberto
    ANNALS OF HEMATOLOGY, 2022, 101 (10) : 2231 - 2239
  • [40] Correction to: Low‑risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera
    Ana Triguero
    Alexandra Pedraza
    Manuel Perez‑Encinas
    María Isabel Mata‑Vazquez
    Patricia Vélez
    Laura Fox
    Montse Gomez‑Calafat
    Regina Garcia‑Delgado
    Mercedes Gasior
    Francisca Ferrer‑Marin
    Valentín Garcia‑Gutierrez
    Anna Angona
    María Teresa Gomez‑Casares
    Beatriz Cuevas
    Clara Martínez
    Raúl Pérez
    José María Raya
    Lucía Guerrero
    Ilda Murillo
    Beatriz Bellosillo
    Juan Carlos Hernandez‑Boluda
    Cristina Sanz
    Alberto Alvarez‑Larran
    Annals of Hematology, 2022, 101 : 2819 - 2820